文献速递胸部CT

三维卷积神经网络识别肺腺癌患者表皮生长因子受体突变状态

Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks.
PubMed 文献 · Br J Radiol · 2018-08-13

研究纳入2012至2015年503例接受手术的中国人肺腺癌患者,用术前CT构建三维卷积神经网络识别EGFR突变状态。独立验证集中CNN的AUC为0.776,融合临床特征(性别和吸烟史)的模型AUC为0.838、准确率77.2%、敏感度75.8%、特异度79.1%。

要点

  • 融合CNN与性别、吸烟史的模型在独立验证集AUC为0.838,优于单用CNN的0.776。
  • 最佳诊断决策点下融合模型准确率77.2%、敏感度75.8%、特异度79.1%。
  • 作者认为CNN可能反映肿瘤空间异质性,性能可通过扩大训练集和优化网络结构进一步提升。

核心结论

  • CNN表现出识别肺腺癌患者EGFR突变状态的可能能力,或有助于临床决策。

研究设计与样本

  • 2012至2015年纳入503例接受手术的中国肺腺癌患者,从手术切除标本检测病理类型和EGFR突变 status,术前采集CT图像,患者被随机分配训练或验证CNN,以AUC、敏感度、特异度和准确率量化性能。

诊断标准与关键数值

  • 训练集EGFR突变(外显子19缺失或外显子21 L858R)为215/345(62.3%),独立验证集为91/158(57.6%);独立验证集CNN的AUC为0.776(范围0.702-0.849,p<0.0001),CNN与临床特征(性别和吸烟史)融合模型的AUC为0.838(范围0.778-0.899,p<0.0001),最佳诊断决策点下融合模型准确率77.2%、敏感度75.8%、特异度79.1%。

局限性

  • 作者指出CNN有一定诊断能力,其性能可通过增加训练集、优化网络结构和训练策略进一步提升。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: Genetic phenotype plays a central role in making treatment decisions of lung adenocarcinoma, especially the tyrosine-kinase-inhibitors-sensitive mutations of the epidermal growth factor receptor (EGFR) gene. We constructed three-dimensional convolutional neural networks (CNN) to analyze underlying patterns in CT images that could indicate that EGFR gene mutation status but are invisible to human eyes.

METHODS:: From 2012 to 2015, 503 Chinese patients with lung adenocarcinoma that had underwent surgery were included. Pathological types and EGFR mutation status were tested from surgical resections. EGFR mutations (exon 19 deletion or exon 21 L858R) were found in 215/345 (62.3%) and 91/158 (57.6%) patients in the training and independent validation set, respectively. CT images were taken before any invasive operation. The patients were randomly chosen to train the CNNs or validate the CNNs' performance. The performance was quantified using area under receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy.

RESULTS:: The CNNs showed an AUC of 0.776 (range: 0.702-0.849, p< 0.0001) in the independent validation set and a fusion model of CNNs and clinical features (sex and smoking history) showed an AUC of 0.838 (range: 0.778-0.899, p< 0.0001), accuracy of 77.2%, sensitivity of 75.8% and specificity of 79.1% at the best diagnostic decision point.

CONCLUSION:: The CNN exhibits potential ability to identify EGFR mutation status in patients with lung adenocarcinoma which might help make clinical decisions.

ADVANCES IN KNOWLEDGE:: The CNN showed some diagnostic power and its performance could be further improved by increasing the training set, optimizing the network structure and training strategy. Medical image based CNN has the potential to reflect spatial heterogeneity.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Xiong JF, Jia TY, Li XY, et al. Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks. Br J Radiol. 2018. PMID: 30059241. doi:10.1259/bjr.20180334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。